<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4884">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04644640</url>
  </required_header>
  <id_info>
    <org_study_id>20-01584</org_study_id>
    <nct_id>NCT04644640</nct_id>
  </id_info>
  <brief_title>Telerehabilitation Following Meniscectomy</brief_title>
  <official_title>Telerehabilitation Following Meniscectomy: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Telerehabilitation is a form of tele-treatment in which rehabilitation services are dispensed&#xD;
      at patients' home utilizing video telecommunication services with real-time synchronous&#xD;
      exchange of information. Since telerehabilitation was found to be equally effective as&#xD;
      conventional therapy, it was being practiced even before the COVID times, however it was&#xD;
      truly valuable during the lockdown. The advantages of telerehabilitation include reducing&#xD;
      unnecessary travel to the hospital and person to person contact while maintaining social&#xD;
      distancing. While some of the patients are truly staying at remote areas, others are unable&#xD;
      to manage travel in the lockdown period. Telemedicine offers the opportunity to deliver&#xD;
      rehabilitative services in the patients' home, closing geographic, physical, and motivational&#xD;
      gaps. Punctuality on either side is also assured since the travel times are saved on both the&#xD;
      ends.&#xD;
&#xD;
      The purpose of the proposed study is to evaluate telerehabilitation vs in-person&#xD;
      rehabilitation following Meniscectomy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2020</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale (VAS) Score</measure>
    <time_frame>up to 1 year post-op</time_frame>
    <description>VAS is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between &quot;no pain&quot; and &quot;worst pain.&quot; The total score ranges from 0-10. The higher the score, the worse the pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>International Knee Documentation Committee (IKDC) Score</measure>
    <time_frame>up to 1 year post-op</time_frame>
    <description>The IKDC is a patient-completed tool, which contains sections on knee symptoms (7 items), function (2 items), and sports activities (2 items). Scores range from 0 points (lowest level of function or highest level of symptoms) to 100 points (highest level of function and lowest level of symptoms).</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Meniscectomy</condition>
  <arm_group>
    <arm_group_label>Telerehabilitation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>In-Person Rehabilitation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telerehabilitation Therapy</intervention_name>
    <description>Rehabilitation services will be dispensed at patients' home utilizing video telecommunication services with real-time synchronous exchange of information - range of motion exercises for the knee, proprioception and balance training</description>
    <arm_group_label>Telerehabilitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>In-person Rehabilitation Therapy</intervention_name>
    <description>Range of motion exercises for the knee, proprioception and balance training</description>
    <arm_group_label>In-Person Rehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Scheduled for meniscectomy&#xD;
&#xD;
          -  Age 18-75&#xD;
&#xD;
          -  Ability to comply with a standardized postoperative protocol&#xD;
&#xD;
          -  Willing and able to provide consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant patient&#xD;
&#xD;
          -  Age &gt;75 years, or &lt; 18&#xD;
&#xD;
          -  Previous knee surgery&#xD;
&#xD;
          -  Unable to speak English or perform informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kirk Campbell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kirk Campbell, MD</last_name>
    <phone>212-263-9700</phone>
    <email>kirk.campbell@nyulangone.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eoghan Hurley, MB, BCh, MCh</last_name>
    <phone>212-263-9700</phone>
    <email>eoghan.hurley@nyulangone.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NYU Langone Health</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Kirk Campbell, MD</last_name>
      <email>kirk.campbell@nyulangone.org</email>
    </contact>
    <contact_backup>
      <last_name>Eoghan Hurley, MB, BCh, MCh</last_name>
      <email>eoghan.hurley@nyulangone.org</email>
    </contact_backup>
    <investigator>
      <last_name>Kirk Campbell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Alaia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laith Jazrawi, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillem Gonzalez-Lomas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric Strauss, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 20, 2020</study_first_submitted>
  <study_first_submitted_qc>November 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 25, 2020</study_first_posted>
  <last_update_submitted>November 20, 2020</last_update_submitted>
  <last_update_submitted_qc>November 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 25, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data that underlie the results reported in this article, after deidentification (text, tables, figures, and appendices) will be shared upon reasonable request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.</ipd_time_frame>
    <ipd_access_criteria>The investigator who proposed to use the data will have access to the data upon reasonable request. Requests should be directed to kirk.campbell@nyulangone.org. To gain access, data requestors will need to sign a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

